These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 24464932

  • 1. Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models.
    Wu CK, Wang YC, Lee JK, Chang SN, Su MY, Yeh HM, Su MJ, Chen JJ, Chiang FT, Hwang JJ, Lin JL, Tsai CT.
    Eur J Heart Fail; 2014 Feb; 16(2):163-72. PubMed ID: 24464932
    [Abstract] [Full Text] [Related]

  • 2. Circulating Connective Tissue Growth Factor Is Associated with Diastolic Dysfunction in Patients with Diastolic Heart Failure.
    Chi H, Feng H, Shang X, Jiao J, Sun L, Jiang W, Meng X, Fan Y, Lin X, Zhong J, Yang X.
    Cardiology; 2019 Feb; 143(3-4):77-84. PubMed ID: 31466059
    [Abstract] [Full Text] [Related]

  • 3. Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.
    Wu CK, Su MY, Lee JK, Chiang FT, Hwang JJ, Lin JL, Chen JJ, Liu FT, Tsai CT.
    Sci Rep; 2015 Nov 19; 5():17007. PubMed ID: 26582585
    [Abstract] [Full Text] [Related]

  • 4. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
    Brooks BA, Franjic B, Ban CR, Swaraj K, Yue DK, Celermajer DS, Twigg SM.
    Diabetes Obes Metab; 2008 Sep 19; 10(9):739-46. PubMed ID: 17941867
    [Abstract] [Full Text] [Related]

  • 5. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.
    Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, Maeno T, Nishida T, Kubota S, Takigawa M, Kurabayashi M.
    Hypertension; 2007 May 19; 49(5):1120-7. PubMed ID: 17372041
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH.
    Basic Res Cardiol; 2010 May 19; 105(3):399-407. PubMed ID: 19902320
    [Abstract] [Full Text] [Related]

  • 7. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.
    Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, Suguta M, Yokoyama T, Tada H, Toyama T, Adachi H, Naito S, Oshima S, Nishida T, Kubota S, Takigawa M, Kurabayashi M.
    Eur J Heart Fail; 2008 Apr 19; 10(4):373-9. PubMed ID: 18337169
    [Abstract] [Full Text] [Related]

  • 8. Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor.
    Zhang J, Chang L, Chen C, Zhang M, Luo Y, Hamblin M, Villacorta L, Xiong JW, Chen YE, Zhang J, Zhu X.
    Cardiovasc Res; 2011 Jul 01; 91(1):90-8. PubMed ID: 21382976
    [Abstract] [Full Text] [Related]

  • 9. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Zhang Y, Yan H, Guang GC, Deng ZR.
    Clin Exp Hypertens; 2017 Jul 01; 39(2):168-174. PubMed ID: 28287886
    [Abstract] [Full Text] [Related]

  • 10. Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy.
    Koshman YE, Sternlicht MD, Kim T, O'Hara CP, Koczor CA, Lewis W, Seeley TW, Lipson KE, Samarel AM.
    J Mol Cell Cardiol; 2015 Dec 01; 89(Pt B):214-22. PubMed ID: 26549358
    [Abstract] [Full Text] [Related]

  • 11. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z, Magga J, Alakoski T, Ulvila J, Piuhola J, Vainio L, Kivirikko KI, Vuolteenaho O, Ruskoaho H, Lipson KE, Signore P, Kerkelä R.
    Hypertension; 2014 Jun 01; 63(6):1235-40. PubMed ID: 24688123
    [Abstract] [Full Text] [Related]

  • 12. [Expression of connective tissue growth factor in cardiomyocyte of young rats with heart failure and benazepril intervention].
    Zhang Q, Yi QJ, Qian YR, Li R, Deng B, Wang Q.
    Zhonghua Er Ke Za Zhi; 2006 Oct 01; 44(10):733-7. PubMed ID: 17229371
    [Abstract] [Full Text] [Related]

  • 13. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
    Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE.
    Circ Res; 2009 Jan 30; 104(2):170-8, 6p following 178. PubMed ID: 19096030
    [Abstract] [Full Text] [Related]

  • 14. Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction.
    Carluccio E, Biagioli P, Zuchi C, Bardelli G, Murrone A, Lauciello R, D'Addario S, Mengoni A, Alunni G, Ambrosio G.
    Int J Cardiovasc Imaging; 2016 Jul 30; 32(7):1071-80. PubMed ID: 27076221
    [Abstract] [Full Text] [Related]

  • 15. CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload.
    Gravning J, Ahmed MS, von Lueder TG, Edvardsen T, Attramadal H.
    Int J Cardiol; 2013 Oct 03; 168(3):2049-56. PubMed ID: 23452880
    [Abstract] [Full Text] [Related]

  • 16. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
    Iwamoto M, Hirohata S, Ogawa H, Ohtsuki T, Shinohata R, Miyoshi T, Hatipoglu FO, Kusachi S, Yamamoto K, Ninomiya Y.
    Hypertens Res; 2010 Dec 03; 33(12):1305-11. PubMed ID: 20944640
    [Abstract] [Full Text] [Related]

  • 17. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction.
    Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kühl U, Schultheiss HP, Tschöpe C.
    J Am Coll Cardiol; 2011 Feb 22; 57(8):977-85. PubMed ID: 21329845
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
    Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ.
    J Am Coll Cardiol; 2008 Nov 04; 52(19):1574-80. PubMed ID: 19007595
    [Abstract] [Full Text] [Related]

  • 19. Induction of myocardial connective tissue growth factor in pacing-induced heart failure in pigs.
    Ahmed MS, von Lueder TG, Øie E, Kjekshus H, Attramadal H.
    Acta Physiol Scand; 2005 May 04; 184(1):27-36. PubMed ID: 15847641
    [Abstract] [Full Text] [Related]

  • 20. Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF/MicroRNA-133a Axis.
    Angelini A, Li Z, Mericskay M, Decaux JF.
    PLoS One; 2015 May 04; 10(10):e0139858. PubMed ID: 26440278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.